Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Shares Outstanding (Weighted Average) (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $51.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 158.36% to $51.4 million in Q4 2025 year-over-year; TTM through Oct 2025 was $51.4 million, a 158.36% increase, with the full-year FY2025 number at $24.6 million, up 23.63% from a year prior.
  • Shares Outstanding (Weighted Average) was $51.4 million for Q4 2025 at Kestra Medical Technologies, roughly flat from $51.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $51.4 million in Q4 2025 to a low of $19.9 million in Q1 2024.